BMAL2 and cancer: To investigate the correlation between ARNTL2 expression and cancer prognosis, we analyzed the hazard ratio statistics of overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI) for each cancer type included in this study.